SMAIO announced the appointment of Matthieu Ville as Chief Commercial Officer (CCO). Matthieu Ville is a French-American citizen with over 15 years of leadership in MedTech innovation and commercialization across continents. He has held key strategic roles focused on developing and scaling both patient-specific and open-platform solutions for leading MedTech companies such as Medicrea/Medtronic (UNiD ASI solution) and eCential Robotics (eCential Robotics Open Platform).
Graduated from Paris Sorbonne University, Matthieu Ville began his career in finance, before joining the spine industry at Medicrea, where he progressed to Marketing Director. There, he played a pivotal role in the development and sales of the UNiD ASI patient-specific platform and more than 10 spinal systems ranging from cervical to iliac. Building on this success, Matthieu joined NuVasive in San Diego (CA), where he led the worldwide upstream marketing team for enabling technologies, overseeing the Pulse digital and analytics product portfolio, driving its launch across three continents, and establishing the collaboration with SMAIO.
Most recently, Matthieu served as Vice President of Marketing at eCential Robotics, leading the marketing and clinical team for the imaging and robotics portfolio, while actively contributing to the company's U.S. implantation and expansion through system sales and company partnerships. In his new role, Matthieu Ville will be leveraging SMAIO's decades-long legacy of spinal science and surgical data intelligence, which has laid the foundation for a holistic, patient-centric approach to spinal realignment, embodied in the unique i-Kontrol smart realignment ecosystem. He will lead SMAIO's global commercial and marketing efforts to expand adoption of i-Kontrol and the recently launched KEOPS-4ME open platform in the United States.
